Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

769 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series: Selected Topics in Malignant Pleural Disease.
Chrissian AA, Abbas H, Chaddha U, Debiane LG, DeBiasi E, Filsoof D, Hashmi MD, Morton C, Naselsky WC, Pannu J, Ronaghi R, Salguero BD, Salmon C, Stewart SJ, Channick CL. Chrissian AA, et al. Among authors: abbas h. J Bronchology Interv Pulmonol. 2024 Dec 20;32(1):e0999. doi: 10.1097/LBR.0000000000000999. eCollection 2025 Jan 1. J Bronchology Interv Pulmonol. 2024. PMID: 39704161 Review.
Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms.
Senapati J, Loghavi S, Garcia-Manero G, Tang G, Kadia T, Short NJ, Abbas HA, Arani N, DiNardo CD, Borthakur G, Pemmaraju N, Oran B, Shpall E, Popat U, Champlin R, Pierce S, Arora S, Issa G, Yilmaz M, Patel K, Takahashi K, Montalban-Bravo G, Hammond D, Haddad FG, Ravandi F, Kantarjian HM, Daver NG. Senapati J, et al. Among authors: abbas ha. Haematologica. 2024 Dec 12. doi: 10.3324/haematol.2024.286465. Online ahead of print. Haematologica. 2024. PMID: 39665206 Free article.
Impact of Measurable Residual Disease Clearance Kinetics in Patients with AML Undergoing Intensive Chemotherapy.
Jen WY, Sasaki K, Ravandi F, Kadia TM, Wang SA, Wang W, Loghavi S, Daver NG, DiNardo CD, Issa GC, Abbas HA, Nasnas C, Bataller A, Urrutia S, Karrar OS, Pierce SA, Kantarjian HM, Short NJ. Jen WY, et al. Among authors: abbas ha. Blood Adv. 2024 Dec 4:bloodadvances.2024013826. doi: 10.1182/bloodadvances.2024013826. Online ahead of print. Blood Adv. 2024. PMID: 39631072
Calciphylaxis in a Patient on Hemodialysis: A Case Report.
Metwally Y, Abbas H, Jeyalan V, Khanfar A. Metwally Y, et al. Among authors: abbas h. Cureus. 2024 Nov 27;16(11):e74558. doi: 10.7759/cureus.74558. eCollection 2024 Nov. Cureus. 2024. PMID: 39606133 Free PMC article.
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.
Jen WY, Marvin-Peek J, Kantarjian HM, Alvarado Y, Borthakur G, Jabbour E, Wierda W, Kadia TM, Daver NG, DiNardo CD, Short NJ, Jain N, Ferrajoli A, Kornblau S, Yilmaz M, Ohanian M, McCue D, Burger J, Hammond D, Patel K, Issa GC, Pemmaraju N, Sasaki K, Maiti A, Abbas HA, Chien K, Takahashi K, Haddad F, Bose P, Masarova L, Montalban-Bravo G, Swaminathan M, Brandt M, Pierce S, Garcia-Manero G, Ravandi F. Jen WY, et al. Among authors: abbas ha. Cancer. 2024 Nov 25. doi: 10.1002/cncr.35662. Online ahead of print. Cancer. 2024. PMID: 39584789
769 results